Benjamin Lewis
No Rating Available
(Learn About Our Rating System)

Benjamin Lewis, MD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Mental Health Institute

501 Chipeta Way
Salt Lake City , UT 84108
801-583-2500
Get Directions

  • Benjamin Lewis, MD, Associate Professor (Clinical), practices inpatient adult psychiatry at the University of Utah Huntsman Mental Health Institute where his clinical interests involve the diagnosis and treatment of major psychiatric disorders. He has additional interests in medical ethics, the philosophy of psychiatry, and the emerging science and clinical applications of psychedelic medicine.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Psychiatry)

  • Benjamin Lewis, MD, Associate Professor (Clinical), practices inpatient adult psychiatry at the University of Utah Huntsman Mental Health Institute where his clinical interests involve the diagnosis and treatment of major psychiatric disorders. He has additional interests in medical ethics, the philosophy of psychiatry, and the emerging science and clinical applications of psychedelic medicine.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Associate Professor (Clinical)
    Academic Divisions Adult Psychiatry
    Board Certification
    American Board of Psychiatry & Neurology (Psychiatry)

    Education history

    Undergraduate English [Magna cum Laude] - Harvard University A.B.
    Professional Medical Medicine - University of Iowa College of Medicine M.D.
    Residency Adult Psychiatry - University of Utah Resident
    Chief Resident University of Utah Assistant Chief Resident
    Chief Resident University of Utah Chief Resident

    Selected Publications

    Journal Article

    1. Case GA, Pippitt KA, Lewis B (2018). Shame. Perspectives on medical education, 7(Suppl 1), 12-15. (Read full publication)
    2. Lewis BR, Byrne (2021). Update on Psychedelic Therapies for Mental Health. Clinical and Forensic Toxicology News, 1-5.
    3. Kious BM, Schwartz Z, Lewis B (2022). Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers. Journal of psychopharmacology (Oxford, England), 37(1), 45-48.
    4. Kious BM, Lewis BR, Kim SY (2023). Epistemic injustice and the psychiatrist. Psychological medicine, 53(1), 1-5. (Read full publication)
    5. Lewis BR, Hendrick J, Byrne K, Garland E, Thielking P, Beck (2023). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. Journal of psychedelic studies, https://doi.org/10.1556/2054.2022.00222.
    6. Byrne K, Lindsay S, Baker N, Schmutz C, Lewis (2023). In Naturalistic Psychedelic Use, Group Use is Common and Acceptable. Journal of psychedelic studies, https://doi.org/10.1556/2054.2023.00261.
    7. Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking (2023). HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. Journal of pain and symptom management, 66(3), 258-269. (Read full publication)
    8. Kious BM, Lewis BR, Kim SY (2023). 'What does epistemic injustice add? A response to Grim and Aftab'. Psychological medicine, 53(12), 5879-5881. (Read full publication)
    9. Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland E (2025). Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. PLoS medicine, 22(9), e1004519. (Read full publication)
    10. Benjamin R. Lewis MD, Matthew J Reid PhD, Andrew Novick MD, Kevin Byrne MD, Mark J. Niciu MD, PhD, Gregory A. Fonzo PhD, Thomas Meyer PhD, David Feifel MD, PhD, Rifaat El-Mallakh MD, Jair Soares MD, PhD, Trisha Suppes MD, PhD, Frederick S. Barrett Ph Challenges with Clinical Trial Participants in Studies with Classical Psychedelics: A Position Statement from the National Network of Depression Centers’ Task Group on Psychedelics and Related Compounds. . Journal of Psychopharmacology,
    11. Lewis BR, Garland E Is Ketamine Really a Dissociative? Effects of Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement on Interoceptive Awareness in Patients with Opioid Use Disorder Treated with Buprenorphine. under review,
    12. Lewis BR, Garland E, Schwartz Z, Xin Y, Byrne K, Kious What’s Good for the Goose? Study Participant Perceptions as to the Relevance of Therapist and Study Team Prior Personal Psychedelic Experience. under review,

    Review

    1. Lewis BR, Byrne (2021). Is MDD the right target for early-stage psychedelic-assisted therapy trials?. Journal of psychedelic studies, 5(2), 65-68.
    2. Lewis BR, Byrne (2023). A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. Focus (American Psychiatric Publishing), 21(3), 247-256. (Read full publication)
    3. Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett F (2025). Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds. EClinicalMedicine, 89, 103517. (Read full publication)

    Book Chapter

    1. Lewis BR, Kious B (2015). The organic-functional distinction.

    Commentary

    1. Lewis B (2015). "The Drugs Didn't Mix: On the Overvaluation of Misvaluation". Philosophy, psychiatry, & psychology, 22(1), 41-43.
    2. Lewis B (2021). Some aspects of containment matter. Philosophy, psychiatry, & psychology, 28(3), 223-225.
    3. Lewis BR, Byrne K, Beck (2023). Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer). Journal of anesthesiology and pain therapy, 4(3), 1-3.

    Editorial

    1. Loughlin M, Bluhm R, Fuller J, Buetow S, Borgerson K, Lewis BR, Kious B (2015). Diseases, patients and the epistemology of practice: mapping the borders of health, medicine and care. Journal of evaluation in clinical practice, 21(3), 357-64. (Read full publication)

    Letter

    1. Kious BM, Lewis B (2019). Classifying psychiatric disorders as communicable diseases. The lancet. Psychiatry, 6(1), 13-14. (Read full publication)
    2. Kious BM, Lewis BR, Kim SY (2023). What does epistemic injustice add? A response to Grim and Aftab . Psychological medicine, 53(12), 5879-5881.

    Research Lab

  • News & Podcasts

    News